​

Colgate-Palmolive (CL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CL Stock Forecast

Colgate-Palmolive stock forecast is as follows: an average price target of $110.50 (represents a 23.37% upside from CL’s last price of $89.57) and a rating consensus of 'Buy', based on 19 wall street analysts offering a 1-year stock forecast.

CL Price Target

The average price target for Colgate-Palmolive (CL) is $110.50 based on 1-year price targets from 19 Wall Street analysts in the past 3 months, with a price target range of $121.00 to $100.00. This represents a potential 23.37% upside from CL's last price of $89.57.

CL Analyst Ratings

Buy

According to 19 Wall Street analysts, Colgate-Palmolive's rating consensus is 'Buy'. The analyst rating breakdown for CL stock is 0 'Strong Buy' (0.00%), 12 'Buy' (63.16%), 6 'Hold' (31.58%), 1 'Sell' (5.26%), and 0 'Strong Sell' (0.00%).

Colgate-Palmolive Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2024Korinne WolfmeyerPiper Sandler$121.00$103.3117.12%35.09%
Sep 16, 2024Chris CareyWells Fargo$100.00$105.73-5.42%11.64%
Jul 22, 2024Mark AstrachanStifel Nicolaus$105.00$98.087.06%17.23%
May 28, 2024Dara MohsenianMorgan Stanley$103.00$93.3010.40%14.99%
May 15, 2024Chris GrajaArgus Research$107.00$94.5713.14%19.46%
Apr 29, 2024Steve PowersDeutsche Bank$98.00$90.138.74%9.41%
Apr 29, 2024Mark AstrachanStifel Nicolaus$95.00$91.014.38%6.06%
Apr 10, 2024Mark AstrachanStifel Nicolaus$94.00$87.657.24%4.95%
Apr 08, 2024Robert OttensteinEvercore ISI$96.00$87.889.24%7.18%
Jan 29, 2024Olivia TongRaymond James$91.00$83.728.69%1.60%
Jul 28, 2023Chris CaseyWells Fargo$81.00$75.627.11%-9.57%
Jan 13, 2023J.P. Morgan$86.00$77.6110.81%-3.99%
Jan 03, 2023Barclays$80.00$78.022.54%-10.68%
Dec 06, 2022Deutsche Bank$87.00$77.0512.91%-2.87%
Oct 18, 2022Kaumil GajrawalaCredit Suisse$85.00$72.8216.73%-5.10%
Oct 03, 2022Wells Fargo$75.00$70.256.76%-16.27%
Aug 08, 2022Chris CareyWells Fargo$80.00$80.43-0.53%-10.68%
Aug 02, 2022Barclays$74.00$81.10-8.75%-17.38%
Aug 01, 2022UBS$90.00$80.2212.18%0.48%
Jul 21, 2022J.P. Morgan$78.00$75.523.28%-12.92%
May 23, 2022Barclays$71.00$75.13-5.50%-20.73%
May 03, 2022Barclays$77.00$75.182.42%-14.03%
May 03, 2022Atlantic Equities$80.00$75.186.41%-10.68%
May 02, 2022Deutsche Bank$88.00$75.3716.76%-1.75%
May 02, 2022Morgan Stanley$82.00$77.066.41%-8.45%
Apr 30, 2022Andrea Faria TeixeiraJ.P. Morgan$79.00$77.052.53%-11.80%
Apr 03, 2022Jason EnglishGoldman Sachs$95.00$76.4224.31%6.06%
Jan 31, 2022Kaumil GajrawalaCredit Suisse$90.00$82.459.16%0.48%
Jan 31, 2022Wendy NicholsonCitigroup$86.00$82.454.31%-3.99%
Jan 31, 2022Christopher CareyWells Fargo$76.00$82.45-7.82%-15.15%
Jan 05, 2022Kevin GrundyJefferies$89.00$84.765.00%-0.64%
Oct 05, 2021Bryan SpillaneBank of America Securities$80.00$73.578.74%-10.68%
Oct 05, 2021Peter GromUBS$89.00$73.5720.97%-0.64%
Aug 02, 2021Mark AstrachanStifel Nicolaus$88.00$78.6311.92%-1.75%

The latest Colgate-Palmolive stock forecast, released on Sep 23, 2024 by Korinne Wolfmeyer from Piper Sandler, set a price target of $121.00, which represents a 17.12% increase from the stock price at the time of the forecast ($103.31), and a 35.09% increase from CL last price ($89.57).

Colgate-Palmolive Price Target by Period

1M3M12M
# Anlaysts--9
Avg Price Target--$102.11
Last Closing Price$89.57$89.57$89.57
Upside/Downside-100.00%-100.00%14.00%

In the current month, the average price target of Colgate-Palmolive stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Colgate-Palmolive's last price of $89.57. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 28, 2024Cowen & Co.BuyBuyHold
Sep 23, 2024Piper SandlerOverweightInitialise
Sep 16, 2024Wells FargoEqual-WeightUnderweightDowngrade
Sep 09, 2024Deutsche BankBuyHoldDowngrade
Jul 29, 2024Cowen & Co.BuyBuyHold
Jul 29, 2024Morgan StanleyOverweightOverweightHold
Jul 26, 2024HSBCHoldDowngrade
Jul 24, 2024JefferiesHoldDowngrade
Jul 22, 2024Cowen & Co.BuyInitialise
Jul 19, 2024BarclaysEqual-WeightEqual-WeightHold
Jul 18, 2024Evercore ISIOutperformOutperformHold
Jul 17, 2024Deutsche BankBuyBuyHold
Jul 10, 2024CitigroupBuyBuyHold
Jun 24, 2024Exane BNP ParibasOutperformInitialise
May 28, 2024Morgan StanleyOverweightOverweightHold
Apr 29, 2024Deutsche BankBuyBuyHold
Apr 29, 2024RBC CapitalSector PerformSector PerformHold
Apr 29, 2024Bank of America SecuritiesBuyBuyHold
Apr 16, 2024CitigroupBuyBuyHold
Apr 12, 2024BarclaysEqual-WeightEqual-WeightHold
Apr 08, 2024Evercore ISIOutperformOutperformHold
Mar 21, 2024CFRABuyUpgrade
Jan 29, 2024UBSBuyBuyHold
Jan 29, 2024Wells FargoEqual-WeightEqual-WeightHold
Jan 29, 2024Raymond JamesOutperformUpgrade
Oct 16, 2023Wells FargoEqual-WeightBuyUpgrade
Jul 28, 2023Deutsche BankBuyBuyHold
Jul 28, 2023Goldman SachsBuyBuyHold
Jul 28, 2023Wells FargoEqual-WeightEqual-WeightHold
Jul 28, 2023Morgan StanleyOverweightOverweightHold
Jan 03, 2023Wells FargoEqual-WeightEqual-WeightHold
Jan 03, 2023BarclaysEqual-WeightEqual-WeightHold
Dec 06, 2022Deutsche BankBuyBuyHold
Oct 18, 2022Credit SuisseOutperformOutperformHold
Oct 18, 2022Deutsche BankBuyBuyHold
Oct 03, 2022Wells FargoEqual-WeightEqual-WeightHold
Aug 02, 2022BarclaysEqual-WeightEqual-WeightHold
Aug 01, 2022Wells FargoEqual-WeightNegativeUpgrade
Aug 01, 2022UBSBuyBuyHold
Aug 01, 2022Wells FargoEqual-WeightUpgrade
May 23, 2022BarclaysEqual-WeightEqual-WeightHold
May 03, 2022Atlantic EquitiesNeutralDowngrade
May 02, 2022Deutsche BankBuyBuyHold
May 02, 2022Morgan StanleyEqual-WeightEqual-WeightHold
Apr 03, 2022Goldman SachsBuyBuyHold

Colgate-Palmolive's last stock rating was published by Cowen & Co. on Oct 28, 2024. The company gave CL a "Buy" rating, the same as its previous rate.

Colgate-Palmolive Financial Forecast

Colgate-Palmolive Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue-----------------$4.92B$4.82B$4.77B$4.63B$4.46B$4.48B$4.40B$4.40B$4.41B$4.26B$4.34B$4.32B$4.15B
Avg Forecast$5.57B$5.54B$5.51B$5.44B$5.32B$5.31B$5.27B$5.23B$5.09B$5.09B$5.03B$5.01B$4.98B$5.01B$5.00B$4.96B$4.89B$4.81B$4.70B$4.59B$4.59B$4.47B$4.35B$4.40B$4.42B$4.40B$4.25B$4.26B$4.15B$3.99B
High Forecast$5.73B$5.69B$5.66B$5.59B$5.47B$5.46B$5.42B$5.37B$5.23B$5.23B$5.17B$5.11B$5.07B$5.01B$5.00B$4.96B$4.96B$5.00B$4.82B$4.71B$4.69B$4.47B$4.35B$4.40B$4.42B$4.40B$4.25B$4.26B$4.15B$3.99B
Low Forecast$5.36B$5.33B$5.30B$5.23B$5.12B$5.11B$5.07B$5.03B$4.90B$4.90B$4.84B$4.78B$4.80B$5.00B$5.00B$4.96B$4.80B$4.72B$4.52B$4.41B$4.49B$4.47B$4.35B$4.40B$4.42B$4.40B$4.25B$4.26B$4.15B$3.99B
# Analysts545454544348109347115954475510759
Surprise %-----------------1.02%1.03%1.04%1.01%1.00%1.03%1.00%1.00%1.00%1.00%1.02%1.04%1.04%

Colgate-Palmolive's average Quarter revenue forecast for Dec 23 based on 7 analysts is $4.89B, with a low forecast of $4.80B, and a high forecast of $4.96B. CL's average Quarter revenue forecast represents a -0.44% decrease compared to the company's last Quarter revenue of $4.92B (Sep 23).

Colgate-Palmolive EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348109347115954475510759
EBITDA-----------------$1.03B$974.00M$1.04B$1.78B$947.00M$1.02B$998.00M$426.00M$946.00M$1.05B$1.05B$988.00M$1.05B
Avg Forecast$1.37B$1.36B$1.35B$1.33B$1.31B$1.30B$1.29B$1.28B$1.25B$1.25B$1.24B$1.23B$1.22B$1.23B$1.23B$1.04B$1.20B$1.18B$1.15B$948.20M$468.60M$1.19B$1.16B$862.00M$1.17B$1.17B$1.13B$1.03B$1.10B$1.06B
High Forecast$1.40B$1.40B$1.39B$1.37B$1.34B$1.34B$1.33B$1.32B$1.28B$1.28B$1.27B$1.25B$1.24B$1.23B$1.23B$1.25B$1.22B$1.23B$1.18B$1.14B$562.32M$1.19B$1.16B$1.03B$1.17B$1.17B$1.13B$1.24B$1.10B$1.06B
Low Forecast$1.32B$1.31B$1.30B$1.28B$1.26B$1.25B$1.24B$1.23B$1.20B$1.20B$1.19B$1.17B$1.18B$1.23B$1.23B$834.42M$1.18B$1.16B$1.11B$758.56M$374.88M$1.19B$1.16B$689.60M$1.17B$1.17B$1.13B$827.00M$1.10B$1.06B
Surprise %-----------------0.87%0.85%1.09%3.80%0.80%0.88%1.16%0.36%0.81%0.93%1.01%0.90%0.99%

7 analysts predict CL's average Quarter EBITDA for Dec 23 to be $1.20B, with a high of $1.22B and a low of $1.18B. This is 16.67% upper than Colgate-Palmolive's previous annual EBITDA (Sep 23) of $1.03B.

Colgate-Palmolive Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348109347115954475510759
Net Income-----------------$708.00M$502.00M$372.00M$43.00M$618.00M$603.00M$559.00M$188.00M$634.00M$703.00M$681.00M$647.00M$698.00M
Avg Forecast$918.23M$897.59M$916.49M$878.15M$856.86M$827.53M$843.57M$803.01M$793.33M$768.77M$787.64M$744.42M$731.78M$728.04M$714.56M$676.39M$700.42M$659.50M$613.42M$614.90M$162.80M$603.06M$584.45M$559.00M$647.92M$655.15M$658.07M$672.38M$629.86M$578.75M
High Forecast$950.79M$929.41M$948.98M$909.28M$887.23M$856.86M$873.48M$831.47M$821.45M$796.02M$815.57M$785.78M$756.45M$728.50M$714.65M$811.67M$716.90M$675.99M$635.17M$737.88M$195.36M$603.06M$584.45M$670.80M$647.92M$655.15M$658.07M$806.86M$629.86M$578.75M
Low Forecast$872.98M$853.34M$871.32M$834.87M$814.62M$786.74M$802.00M$763.43M$754.22M$730.88M$748.82M$711.33M$715.34M$727.57M$714.46M$541.11M$692.17M$643.01M$583.19M$491.92M$130.24M$603.06M$584.45M$447.20M$647.92M$655.15M$658.07M$537.90M$629.86M$578.75M
Surprise %-----------------1.07%0.82%0.60%0.26%1.02%1.03%1.00%0.29%0.97%1.07%1.01%1.03%1.21%

Colgate-Palmolive's average Quarter net income forecast for Dec 23 is $700.42M, with a range of $692.17M to $716.90M. CL's average Quarter net income forecast represents a -1.07% decrease compared to the company's last Quarter net income of $708.00M (Sep 23).

Colgate-Palmolive SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348109347115954475510759
SG&A-----------------$1.82B$1.77B$1.76B$1.63B$1.63B$1.66B$1.64B$1.60B$1.64B$1.57B$1.60B$1.63B$1.52B
Avg Forecast$2.03B$2.02B$2.01B$1.98B$1.94B$1.93B$1.92B$1.90B$1.85B$1.85B$1.83B$1.83B$1.81B$1.82B$1.82B$1.99B$1.78B$1.75B$1.71B$1.81B$1.76B$1.61B$1.57B$1.64B$1.59B$1.59B$1.53B$1.58B$1.50B$1.44B
High Forecast$2.09B$2.07B$2.06B$2.04B$1.99B$1.99B$1.97B$1.96B$1.91B$1.90B$1.88B$1.86B$1.85B$1.83B$1.82B$2.38B$1.81B$1.82B$1.76B$2.17B$2.11B$1.61B$1.57B$1.97B$1.59B$1.59B$1.53B$1.90B$1.50B$1.44B
Low Forecast$1.95B$1.94B$1.93B$1.91B$1.87B$1.86B$1.85B$1.83B$1.78B$1.78B$1.76B$1.74B$1.75B$1.82B$1.82B$1.59B$1.75B$1.72B$1.65B$1.44B$1.41B$1.61B$1.57B$1.31B$1.59B$1.59B$1.53B$1.27B$1.50B$1.44B
Surprise %-----------------1.04%1.03%0.97%0.93%1.01%1.06%1.00%1.00%1.03%1.02%1.01%1.09%1.06%

Colgate-Palmolive's average Quarter SG&A projection for Dec 23 is $1.78B, based on 7 Wall Street analysts, with a range of $1.75B to $1.81B. The forecast indicates a -2.17% fall compared to CL last annual SG&A of $1.82B (Sep 23).

Colgate-Palmolive EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348109347115954475510759
EPS-----------------$0.86$0.61$0.45$0.05$0.74$0.72$0.67$0.22$0.75$0.83$0.80$0.76$0.81
Avg Forecast$1.12$1.09$1.11$1.07$1.04$1.01$1.03$0.98$0.96$0.93$0.96$0.91$0.89$0.89$0.87$0.81$0.85$0.80$0.75$0.70$0.76$0.73$0.71$0.74$0.79$0.80$0.80$0.79$0.76$0.70
High Forecast$1.16$1.13$1.15$1.11$1.08$1.04$1.06$1.01$1.00$0.97$0.99$0.96$0.92$0.89$0.87$0.81$0.87$0.82$0.77$0.72$0.79$0.73$0.71$0.74$0.79$0.80$0.80$0.79$0.76$0.70
Low Forecast$1.06$1.04$1.06$1.02$0.99$0.96$0.98$0.93$0.92$0.89$0.91$0.86$0.87$0.88$0.87$0.81$0.84$0.78$0.71$0.67$0.74$0.73$0.71$0.74$0.79$0.80$0.80$0.79$0.76$0.70
Surprise %-----------------1.07%0.82%0.64%0.07%1.01%1.01%0.90%0.28%0.94%1.04%1.01%0.99%1.15%

According to 7 Wall Street analysts, Colgate-Palmolive's projected average Quarter EPS for Dec 23 is $0.85, with a low estimate of $0.84 and a high estimate of $0.87. This represents a -0.98% decrease compared to CL previous annual EPS of $0.86 (Sep 23).

Colgate-Palmolive Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ELEstée Lauder Companies$82.28$110.6034.42%Hold
ULUnilever$57.27$72.0025.72%Buy
CLColgate-Palmolive$89.57$110.5023.37%Buy
KMBKimberly-Clark$129.67$151.0016.45%Hold
PGProcter & Gamble$166.23$172.403.71%Buy
CLXClorox$157.81$159.501.07%Hold
CHDChurch & Dwight$106.77$106.20-0.53%Hold

CL Forecast FAQ

Is Colgate-Palmolive a good buy?

Yes, according to 19 Wall Street analysts, Colgate-Palmolive (CL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 12 'Buy' recommendations, accounting for 63.16% of CL's total ratings.

What is CL's price target?

Colgate-Palmolive (CL) average price target is $110.5 with a range of $100 to $121, implying a 23.37% from its last price of $89.57. The data is based on 19 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Colgate-Palmolive stock go up soon?

According to Wall Street analysts' prediction for CL stock, the company can go up by 23.37% (from the last price of $89.57 to the average price target of $110.5), up by 35.09% based on the highest stock price target, and up by 11.64% based on the lowest stock price target.

Can Colgate-Palmolive stock reach $130?

CL's average twelve months analyst stock price target of $110.5 does not support the claim that Colgate-Palmolive can reach $130 in the near future.

What are Colgate-Palmolive's analysts' financial forecasts?

Colgate-Palmolive's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $21.13B (high $21.71B, low $20.33B), average EBITDA is $5.18B (high $5.33B, low $4.99B), average net income is $3.33B (high $3.45B, low $3.17B), average SG&A $7.7B (high $7.91B, low $7.41B), and average EPS is $4.05 (high $4.19, low $3.85). CL's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $22.06B (high $22.66B, low $21.22B), average EBITDA is $5.41B (high $5.56B, low $5.21B), average net income is $3.61B (high $3.74B, low $3.43B), average SG&A $8.04B (high $8.25B, low $7.73B), and average EPS is $4.39 (high $4.55, low $4.17).

Did the CL's actual financial results beat the analysts' financial forecasts?

Based on Colgate-Palmolive's last annual report (Dec 2022), the company's revenue was $17.97B, beating the average analysts forecast of $17.81B by 0.86%. Apple's EBITDA was $4.88B, beating the average prediction of $3.68B by 32.71%. The company's net income was $1.78B, missing the average estimation of $1.91B by -6.51%. Apple's SG&A was $6.56B, missing the average forecast of $6.58B by -0.21%. Lastly, the company's EPS was $2.13, missing the average prediction of $2.95 by -27.81%. In terms of the last quarterly report (Sep 2023), Colgate-Palmolive's revenue was $4.92B, beating the average analysts' forecast of $4.81B by 2.10%. The company's EBITDA was $1.03B, missing the average prediction of $1.18B by -12.87%. Colgate-Palmolive's net income was $708M, beating the average estimation of $659.5M by 7.35%. The company's SG&A was $1.82B, beating the average forecast of $1.75B by 3.90%. Lastly, the company's EPS was $0.86, beating the average prediction of $0.802 by 7.26%